Pfizer Pays $35M To Settle AGs' Rapamune Marketing Probe
Pfizer Inc. agreed Wednesday to dole out $35 million to states across the country to settle claims by attorneys general that Wyeth Pharmaceuticals Inc. pushed Rapamune, an immunosuppressive drug used to...To view the full article, register now.
Already a subscriber? Click here to view full article